Akeso’s Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA by Investing.com
Hong Kong, January 26, 2025 /prnewswire/- Akeso, Inc. (9926.hk)("AkesoThe Company (or the…
Litecoin falls 10% in bearish trading By Investing.com
Investing.com - Litecoin was trading at $124.387 on the Investing.com index by…
Motability Operations Group Issue Notes Program Supplement by Investing.com
LONDON - Motability Operations Group plc announced on Thursday the launch of…
Transaction Notification and Publication by Investing.com
LONDON--(BUSINESS WIRE)--Regulatory news: Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (NA:PSH) notes that…
Bouygues reports steady growth, confirms 2024 outlook By Investing.com
During the recent earnings call, Bouygues (EPA:) (EN:EN), a French industrial group,…
CTT reports solid growth in Q3, anticipates strong Q4 By Investing.com
CTT (CTT.LS), the national postal service of Portugal, reported a robust third…
Investing.com Stocks of the Week By Investing.com
Investing.com -- With earnings on track and the US election on the…
Leading Edge Materials closes second and final tranche of private placement with Investing.com
Advanced Materials closes second and final tranche of private placement Vancouver, September…
Middle East concerns drive oil prices higher, rate cut welcomed – Investing.com
Investing.com -- Oil prices rose in Asian markets on Monday as rising…
Needham highlights strong demand for Salesforce.com’s new products and reiterates buy by Investing.com
On Friday, BofA Securities Fortis Inc. (NYSE::CN) (NYSE: FTS) issued an Underperform…
